000			01463 a2200457 4500
005			20250512045445.0
264		0	_c19880307
008			198803s 0 0 eng d
022			_a0379-0363
024	7		_a10.1007/978-3-0348-9299-5_20 _2doi
040			_aNLM _beng _cNLM
100	1		_aPeleska, J
245	0	0	_aHumoral changes during a long-term antihypertensive treatment. _h[electronic resource]
260			_bAgents and actions. Supplements _c1987
300			_a191-6 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aBenzothiadiazines _xtherapeutic use
650	0	4	_aBupranolol _xtherapeutic use
650	0	4	_aDrug Combinations _xtherapeutic use
650	0	4	_aFatty Acids, Unsaturated _xmetabolism
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypertension _xdrug therapy
650	0	4	_aKallikreins _xurine
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPotassium _xurine
650	0	4	_aRenin _xblood
650	0	4	_aSodium _xurine
650	0	4	_aTime Factors
650	0	4	_aTriamterene _xtherapeutic use
700	1		_aJindra, A
700	1		_aJáchymová, M
700	1		_aZvárová, J
700	1		_aSavliková, J
700	1		_aJarolim, M
773	0		_tAgents and actions. Supplements _gvol. 22 _gp. 191-6
856	4	0	_uhttps://doi.org/10.1007/978-3-0348-9299-5_20 _zAvailable from publisher's website
999			_c3330462 _d3330462